Integra Lifesciences Holdings (IART) Operating Margin (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly Operating Margin of 2.93% in Q1 2026, down 44.75% quarter-over-quarter from 5.3% in Q4 2025, and up 698.0% year-over-year from 0.37% in Q1 2025.
Integra Lifesciences Holdings' Operating Margin history runs 18 years deep, the most recent figure standing at 2.93% for Q1 2026.
- In Q1 2026, Operating Margin rose 698.0% year-over-year to 2.93%; the TTM figure through Mar 2026 stood at 28.36% (down 2891.0% YoY), while the FY2025 annual figure was 30.17%, down 3194.0% from the prior year.
- Operating Margin came in at 2.93% for Q1 2026 at Integra Lifesciences Holdings, down from 5.3% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 17.04% in Q4 2022 to a low of 123.36% in Q2 2025.
- A 5-year average of 1.17% and a median of 5.3% in 2025 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin tumbled 12263 bps in 2025 and soared 698 bps in 2026, its largest moves.
- Integra Lifesciences Holdings' Operating Margin stood at 17.04% in 2022, then tumbled by 47 bps to 9.08% in 2023, then fell by 11 bps to 8.05% in 2024, then sank by 34 bps to 5.3% in 2025, then sank by 45 bps to 2.93% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 2.93%, 5.3%, and 2.93% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | 2.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.93% |
| Dec 31, 2025 | 5.30% |
| Sep 30, 2025 | 2.93% |
| Jun 30, 2025 | -123.36% |
| Mar 31, 2025 | -4.05% |
| Dec 31, 2024 | 8.05% |
| Sep 30, 2024 | -2.14% |
| Jun 30, 2024 | -0.72% |
| Mar 31, 2024 | 1.07% |
| Dec 31, 2023 | 9.08% |
| Sep 30, 2023 | 6.95% |
| Jun 30, 2023 | 3.28% |
| Mar 31, 2023 | 9.55% |
| Dec 31, 2022 | 17.04% |
| Sep 30, 2022 | 16.89% |
| Jun 30, 2022 | 15.05% |
| Mar 31, 2022 | 12.26% |
| Dec 31, 2021 | 14.36% |
| Sep 30, 2021 | 14.59% |
| Jun 30, 2021 | 13.30% |
| Mar 31, 2021 | 8.53% |
| Dec 31, 2020 | 13.55% |
| Sep 30, 2020 | 15.54% |
| Jun 30, 2020 | 5.44% |
| Mar 31, 2020 | 7.65% |
| Dec 31, 2019 | 9.13% |
| Sep 30, 2019 | -5.43% |
| Jun 30, 2019 | 11.98% |
| Mar 31, 2019 | 8.98% |
| Dec 31, 2018 | 8.90% |
| Sep 30, 2018 | 6.47% |
| Jun 30, 2018 | 7.55% |
| Mar 31, 2018 | 7.16% |
| Dec 31, 2017 | 1.96% |
| Sep 30, 2017 | 3.82% |
| Jun 30, 2017 | 6.02% |
| Mar 31, 2017 | 3.85% |
| Dec 31, 2016 | 15.95% |
| Sep 30, 2016 | 12.02% |
| Jun 30, 2016 | 8.98% |
| Mar 31, 2016 | 9.33% |
| Dec 31, 2015 | 9.96% |
| Sep 30, 2015 | 4.41% |
| Jun 30, 2015 | 11.45% |
| Mar 31, 2015 | 10.49% |
| Dec 31, 2014 | 13.50% |
| Sep 30, 2014 | 8.66% |
| Jun 30, 2014 | 6.29% |
| Mar 31, 2014 | 4.77% |
| Dec 31, 2013 | 28.60% |
| Sep 30, 2013 | -14.60% |
| Jun 30, 2013 | 2.70% |
| Mar 31, 2013 | -1.11% |
| Dec 31, 2012 | 8.65% |
| Sep 30, 2012 | 9.39% |
| Jun 30, 2012 | 8.57% |
| Mar 31, 2012 | 8.90% |
| Dec 31, 2011 | 3.81% |
| Sep 30, 2011 | 9.05% |
| Jun 30, 2011 | 4.14% |
| Mar 31, 2011 | 11.53% |
| Dec 31, 2010 | 12.45% |
| Sep 30, 2010 | 14.63% |
| Jun 30, 2010 | 13.76% |
| Mar 31, 2010 | 13.11% |
| Dec 31, 2009 | 15.17% |
| Sep 30, 2009 | 13.83% |
| Jun 30, 2009 | 14.42% |